<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: Drug Development (Industry News &amp; Blogs)</title><link>http://www.zibb.com/all/theme/p/Drug+Development</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/all/theme/p/Drug+Development" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Tue, 24 Nov 2009 00:00:00 GMT</pubDate><lastBuildDate>Tue, 24 Nov 2009 00:00:00 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: Drug Development (Industry News &amp; Blogs)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/all/theme/p/Drug+Development</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>Water Purification Accessory for Trace Elemental Analysis</title><link>http://www.pharmaasia.com/article-8090-waterpurificationaccessoryfortraceelementalanalysis-asia.html</link><description>...RSS Feeds More Advertising Information Editorial Information Technical Channels Drug Discovery Drug Development Drug Manufacturing Drug Delivery Clinical Trials Regulatory and Legal Alliances and Mergers QA...</description><guid>http://www.pharmaasia.com/article-8090-waterpurificationaccessoryfortraceelementalanalysis-asia.html</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Tue, 24 Nov 2009 00:00:00 GMT</pubDate><source url="http://www.pharmaasia.com" /></item><item><title>NEW: ASTM D149 - 09 Standard Test Method for Dielectric Breakdown...
      </title><link>http://measurementmedia.com/index.php?name=News&amp;file=article&amp;sid=1506</link><description>... Webinar: Freeze Drying Cycle Development &amp; Scale-Up Tuesday, November 03 Quantitative Model-Based Drug Development Focus of AAPS Workshop Monday, November 02 Surface dissolution imaging gives insight into bioavailability...</description><guid>http://measurementmedia.com/index.php?name=News&amp;file=article&amp;sid=1506</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 21:46:24 GMT</pubDate><source url="http://measurementmedia.com" /></item><item><title>The Side Effect of Developing Obesity Drugs</title><link>http://www.fool.com/investing/high-growth/2009/11/23/the-side-effect-of-developing-obesity-drugs.aspx</link><description>...development of their obesity drugs, and they're the reason investors should be careful when investing in this space. Drug development may be risky, but investing in it can earn you the highest possible returns. “The Next Great Investment...</description><guid>http://www.fool.com/investing/high-growth/2009/11/23/the-side-effect-of-developing-obesity-drugs.aspx</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 21:09:35 GMT</pubDate><source url="http://www.fool.com" /></item><item><title>Indian biotech firm to bring drug research to Birmingham</title><link>http://birmingham.bizjournals.com/birmingham/stories/2009/11/23/daily8.html?ana=from_rss&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%253A+vertical_36+%2528Pharmaceutical+Industry+News%2529</link><description>...remains an issue SRI names new vice president of drug development Southern Research Institute: Quinlan Castle renovations...Research Institute and an Indian firm have formed a drug development partnership that could infuse millions of dollars...</description><guid>http://birmingham.bizjournals.com/birmingham/stories/2009/11/23/daily8.html?ana=from_rss&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%253A+vertical_36+%2528Pharmaceutical+Industry+News%2529</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 20:27:57 GMT</pubDate><source url="http://birmingham.bizjournals.com" /></item><item><title>10 x 20: ID experts call for 10 new antibiotics by 2020 | R&amp;D Mag</title><link>http://rdmag.com/News/Feeds/2009/11/policy-10-x-20-id-experts-call-for-10-new-antibiotics-by/</link><description>...antibacterial drug pipeline work group,' which would be responsible for indentifying strategies to motivate antibiotic drug development." Because this issue is so critically important, IDSA has also urged that the U.S. and EU activities...</description><guid>http://rdmag.com/News/Feeds/2009/11/policy-10-x-20-id-experts-call-for-10-new-antibiotics-by/</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 19:37:38 GMT</pubDate><source url="http://rdmag.com" /></item><item><title>Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carte...
      </title><link>http://www.prnewswire.com/news-releases/immune-design-corp-announces-appointment-of-dr-bruce-la-carter-as-executive-chairman-and-director-71454272.html</link><description>...Hyderabad, India based generic drug maker, QLT, Inc. Vancouver, Canada and the nonprofit Global Alliance TB Drug Development Board, New York, NY. He joins IDC after a long career in the biotechnology and pharmaceutical arena. Dr...</description><guid>http://www.prnewswire.com/news-releases/immune-design-corp-announces-appointment-of-dr-bruce-la-carter-as-executive-chairman-and-director-71454272.html</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 17:48:00 GMT</pubDate><source url="http://www.prnewswire.com" /></item><item><title>YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/...
      </title><link>http://www.zibb.com/article/5688381/YM+BIOSCIENCES+REPORTS+FIRST+PATIENT+IN+PHASE+I+II+TRIAL+OF+JAK+JAK+INHIBITOR+CYT+ENROLLED+BY+CYTOPIA</link><description>...the discovery and development of new drugs to treat cancer and other diseases. Cytopia conducts its research and drug development through subsidiaries based in Melbourne, Australia and California, USA and specializes in developing new small...</description><guid>http://www.zibb.com/article/5688381/YM+BIOSCIENCES+REPORTS+FIRST+PATIENT+IN+PHASE+I+II+TRIAL+OF+JAK+JAK+INHIBITOR+CYT+ENROLLED+BY+CYTOPIA</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 17:00:00 GMT</pubDate><source url="http://www.zibb.com" /></item><item><title>CytRx: Technical Breakout Imminent</title><link>http://seekingalpha.com/article/174834-cytrx-technical-breakout-imminent?source=feed</link><description>...development of high-value human therapeutics. The CytRx drug development pipeline includes programs in clinical development...Protein Design Labs, as global leader of oncology drug development at Sandoz Pharmaceuticals and as director of clinical...</description><guid>http://seekingalpha.com/article/174834-cytrx-technical-breakout-imminent?source=feed</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 15:19:38 GMT</pubDate><source url="http://seekingalpha.com" /></item><item><title>Taking aim at hard-to-treat fungal infections | R&amp;D Mag</title><link>http://www.rdmag.com/News/2009/11/Life-Science-Taking-Aim-At-Hard-To-Treat-Fungal-Infections/</link><description>...treat fungal infections Posted In: R&amp;D Daily | Bacteria | Biology | Biotechnology | Chemistry | Diseases | Drug Development | Genomics &amp; Proteomics | Biology | Chemistry | Modeling | Biotechnology | Pharmaceuticals &amp; Biopharmaceuticals...</description><guid>http://www.rdmag.com/News/2009/11/Life-Science-Taking-Aim-At-Hard-To-Treat-Fungal-Infections/</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 13:43:14 GMT</pubDate><source url="http://www.rdmag.com" /></item><item><title>NanoViricides CEO Presents Lifetime Data from FluCide at Influenz...
      </title><link>http://www.azonano.com/news.asp?newsID=14787</link><description>...relatively low affinities successfully. "Other drug development approaches require discovery of antibodies or chemicals...Conference NanoViricides CEO to Speak Bbout Rapid Drug Development Enabled by Nanoviricides Technology at NanoBusiness2009...</description><guid>http://www.azonano.com/news.asp?newsID=14787</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 13:33:09 GMT</pubDate><source url="http://www.azonano.com" /></item><item><title>NanoViricides Presents FluCide Animal Study Data at Influenza Con...
      </title><link>http://www.nanowerk.com/news/newsid=13657.php</link><description>...effect. This allows the Company to employ virus-binding ligands with relatively low affinities successfully. Other drug development approaches require discovery of antibodies or chemicals with very high affinities, sub-micromolar or better...</description><guid>http://www.nanowerk.com/news/newsid=13657.php</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 13:11:29 GMT</pubDate><source url="http://www.nanowerk.com" /></item><item><title>Receptos Completes $25M Series A Financing (Business Wire)</title><link>http://finance.yahoo.com/news/Receptos-Completes-25M-Series-bw-1178543140.html?x=0&amp;.v=1</link><description>...of novel therapeutics directed at high-value GPCR targets, some of which have not been amenable to successful drug development.” Serving on the board of directors of Receptos are Robert Nelsen (ARCH Venture Partners), Doug Cole...</description><guid>http://finance.yahoo.com/news/Receptos-Completes-25M-Series-bw-1178543140.html?x=0&amp;.v=1</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 13:00:00 GMT</pubDate><source url="http://finance.yahoo.com" /></item><item><title>Experienced Biotech and Regulatory Expert Becomes Formal Member o...
      </title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3668721&amp;HITNO=13&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=biotechnology%20pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R%3adate&amp;R=3668721&amp;THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2348002917%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><description>...Experienced Biotech and Regulatory Expert Becomes Formal Member of the biOasis Team Karkan has over 10 years experience in drug development in the pharmaceutical and biotechnology industry and government. Karkan is currently Senior Science Advisor...</description><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3668721&amp;HITNO=13&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=biotechnology%20pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R%3adate&amp;R=3668721&amp;THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2348002917%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 12:30:15 GMT</pubDate><source url="http://www.bioportfolio.co.uk" /></item><item><title>Receptos Completes $25M Series A Financing</title><link>http://www.biospace.com/news_story.aspx?StoryID=163622&amp;full=1</link><description>...of novel therapeutics directed at high-value GPCR targets, some of which have not been amenable to successful drug development.” Serving on the board of directors of Receptos are Robert Nelsen (ARCH Venture Partners), Doug...</description><guid>http://www.biospace.com/news_story.aspx?StoryID=163622&amp;full=1</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 12:00:00 GMT</pubDate><source url="http://www.biospace.com" /></item><item><title>Vaccine quest boosted by HIV that infects monkeys</title><link>http://www.newscientist.com/article/mg20427353.600-vaccine-quest-boosted-by-hiv-that-infects-monkeys.html</link><description>...Hatziioannou at the Aaron Diamond AIDS Research Center (ADARC) in New York, could guide future vaccine trials, drug development and basic research into the virus. "The potential applications are huge," Hatziioannou says. "It could change...</description><guid>http://www.newscientist.com/article/mg20427353.600-vaccine-quest-boosted-by-hiv-that-infects-monkeys.html</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 11:49:00 GMT</pubDate><source url="http://www.newscientist.com" /></item><item><title>Merck Serono to Expand Research and Development Presence in China</title><link>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=11219</link><description>...Pharmaceuticals ADDS (Advanced Drug Development Services) Adelphi Group...Search Mapi Values Marix Drug Development Limited Marks Sattin Matchtech... The China team will lead drug development for China and...</description><guid>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=11219</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 01:00:00 GMT</pubDate><source url="http://www.pharmiweb.com" /></item><item><title>Merck Serono to Invest More than €150M in R&amp; D Center in China</title><link>http://www.genengnews.com/news/bnitem.aspx?name=69321270</link><description>... The China R&amp;D organization will become one of the key R&amp;D hubs for the company. The China team will lead drug development for China and other Asian countries, for local clinical trials as well as for the participation in global...</description><guid>http://www.genengnews.com/news/bnitem.aspx?name=69321270</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Mon, 23 Nov 2009 00:00:00 GMT</pubDate><source url="http://www.genengnews.com" /></item><item><title>A doctor without borders</title><link>http://www.latimes.com/business/la-fi-himi22-2009nov22,0,5937147.story?track=rss&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+latimes%2Fbusiness+%28L.A.+Times+-+Business%29</link><description>...surgeon and medical professor at age 31. His fortune is tied to his stake in Abraxis BioScience, a Los Angeles drug development company formed from two firms he founded to pursue promising therapies for cancer, diabetes and other devastating...</description><guid>http://www.latimes.com/business/la-fi-himi22-2009nov22,0,5937147.story?track=rss&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+latimes%2Fbusiness+%28L.A.+Times+-+Business%29</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Sun, 22 Nov 2009 08:00:00 GMT</pubDate><source url="http://www.latimes.com" /></item><item><title>Stem cells could be the secret reason why breast is best</title><link>http://www.independent.co.uk/news/science/stem-cells-could-be-the-secret-reason-why-breast-is-best-1825558.html</link><description>...may give us some insight into specific breast diseases and is potentially valuable when it comes to drug discovery and drug development but it is fanciful to think it could provide routine therapies." Post a Comment LiveJournal Subject...</description><guid>http://www.independent.co.uk/news/science/stem-cells-could-be-the-secret-reason-why-breast-is-best-1825558.html</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Sun, 22 Nov 2009 00:00:01 GMT</pubDate><source url="http://www.independent.co.uk" /></item><item><title>Cancer Research Foundation Receives Major Gift from Irwin and Joa...
      </title><link>http://www.prlog.org/10421731-cancer-research-foundation-receives-major-gift-from-irwin-and-joan-jacobs.html</link><description>...specimens and models, the coordination of advanced genomic studies, and the creation of an infrastructure for preclinical drug development. ACCRF has also provided technical assistance to other rare cancer research organizations. For further information...</description><guid>http://www.prlog.org/10421731-cancer-research-foundation-receives-major-gift-from-irwin-and-joan-jacobs.html</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Fri, 20 Nov 2009 18:07:23 GMT</pubDate><source url="http://www.prlog.org" /></item><item><title>Executive Moves: Frontage</title><link>http://www.contractpharma.com/news/2009/11/20/executive_moves%3a_frontage?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+ContractPharmaBreakingNews+%28Contract+Pharma+Breaking+News%29</link><description>...and generic pharmaceutical environments. He has led drug development and technical services at Actavis, Alpharma...S. operations.In addition, Ron has 20 years of drug development and FDA inspection experience from Flavine, Wyeth...</description><guid>http://www.contractpharma.com/news/2009/11/20/executive_moves%3a_frontage?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+ContractPharmaBreakingNews+%28Contract+Pharma+Breaking+News%29</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Fri, 20 Nov 2009 14:16:00 GMT</pubDate><source url="http://www.contractpharma.com" /></item><item><title>Protagen organises protein array user meeting</title><link>http://www.laboratorytalk.com/news/prg/prg106.html</link><description>...applications was organised by Protagen and focused on the increasing relevance of new markers and marker panels for drug development and therapy. The potential of Protagen's Uniarray platform technology for identification and validation...</description><guid>http://www.laboratorytalk.com/news/prg/prg106.html</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Fri, 20 Nov 2009 08:00:00 GMT</pubDate><source url="http://www.laboratorytalk.com" /></item><item><title>Challenging the drug development blueprint: A formulator?s perspe...
      </title><link>http://pharmtech.findpharma.com/pharmtech/data/articlestandard//pharmtech/472009/643177/article.pdf</link><description>...SPformulations.com Challenging the drug development blueprint: A formulator’s...CHARACTERIZATION PRODUCT DRUG DEVELOPMENT SUPPLIES TOXICOLOGY PRODUCT...management throughout Table 2. Drug development stages Major development...</description><guid>http://pharmtech.findpharma.com/pharmtech/data/articlestandard//pharmtech/472009/643177/article.pdf</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Fri, 20 Nov 2009 05:00:00 GMT</pubDate><source url="http://pharmtech.findpharma.com" /></item><item><title>DIA Safety Conference To Explore Solutions To Challenges Facing P...
      </title><link>http://www.prweb.com/releases/DIA/Safety_Conference/prweb3230364.htm</link><description>...and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of drug development and medical product lifecycle management. DIA is led by its volunteer Board of Directors and executive management...</description><guid>http://www.prweb.com/releases/DIA/Safety_Conference/prweb3230364.htm</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Fri, 20 Nov 2009 01:20:38 GMT</pubDate><source url="http://www.prweb.com" /></item><item><title>Almac Doubles Capacity at North Carolina Facility</title><link>http://www.drugdevelopment-technology.com/contractors/contract_research/almac/press28.html</link><description>...Exhibitions Newsletter Advertise With Us About Us Client Area RSS What is RSS For every phase of your drug development Search</description><guid>http://www.drugdevelopment-technology.com/contractors/contract_research/almac/press28.html</guid><category domain="http://www.zibb.com">Drug Development</category><pubDate>Fri, 20 Nov 2009 00:00:00 GMT</pubDate><source url="http://www.drugdevelopment-technology.com" /></item></channel></rss>